ResearcherZhejiang Chinese Medical UniversityNo recent work listed

Xiang Qian

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2023: 1 paper

Papers 1

Qingyihuaji Formula promotes apoptosis and autophagy through inhibition of MAPK/ERK and PI3K/Akt/mTOR signaling pathway on pancreatic cancer in vivo and in vit… Co-author DOI 10.1016/j.jep.2023.116198 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Libin Song · 1 shared paper, 2023 · strength 0.18
- Paper Qingyihuaji Formula promotes apoptosis and autophagy through inhibition of MAPK/ERK and PI3K/Akt/mTOR signaling pathway… DOI 10.1016/j.jep.2023.116198 ↗
Changyu Li · 1 shared paper, 2023 · strength 0.18
- Paper Qingyihuaji Formula promotes apoptosis and autophagy through inhibition of MAPK/ERK and PI3K/Akt/mTOR signaling pathway… DOI 10.1016/j.jep.2023.116198 ↗
Xuming Ji · 1 shared paper, 2023 · strength 0.18
- Paper Qingyihuaji Formula promotes apoptosis and autophagy through inhibition of MAPK/ERK and PI3K/Akt/mTOR signaling pathway… DOI 10.1016/j.jep.2023.116198 ↗
Luming Liu · 1 shared paper, 2023 · strength 0.18
- Paper Qingyihuaji Formula promotes apoptosis and autophagy through inhibition of MAPK/ERK and PI3K/Akt/mTOR signaling pathway… DOI 10.1016/j.jep.2023.116198 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.